FI950383A - Nytt förfarande för framställning av kiralt (((2-brometyl)amino)-metyl)-2-nitro-1H-imidazol-1-etanol och därmed besläktade föreningar - Google Patents

Nytt förfarande för framställning av kiralt (((2-brometyl)amino)-metyl)-2-nitro-1H-imidazol-1-etanol och därmed besläktade föreningar Download PDF

Info

Publication number
FI950383A
FI950383A FI950383A FI950383A FI950383A FI 950383 A FI950383 A FI 950383A FI 950383 A FI950383 A FI 950383A FI 950383 A FI950383 A FI 950383A FI 950383 A FI950383 A FI 950383A
Authority
FI
Finland
Prior art keywords
bromoethyl
chiral
imidazole
nitro
ethanol
Prior art date
Application number
FI950383A
Other languages
English (en)
Finnish (fi)
Other versions
FI950383A0 (sv
Inventor
Gerald Edward Adams
Edward Martin Fielden
Matthew Alexander Naylor
Ian James Stratford
Vladimir Genukh Beylin
Anthony Denver Sercel
Howard Daniel Hollis Showalter
Original Assignee
Warner Lambert Co
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, British Tech Group filed Critical Warner Lambert Co
Publication of FI950383A0 publication Critical patent/FI950383A0/sv
Publication of FI950383A publication Critical patent/FI950383A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI950383A 1992-07-31 1995-01-27 Nytt förfarande för framställning av kiralt (((2-brometyl)amino)-metyl)-2-nitro-1H-imidazol-1-etanol och därmed besläktade föreningar FI950383A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92320992A 1992-07-31 1992-07-31
PCT/US1993/006973 WO1994015922A1 (en) 1992-07-31 1993-07-26 Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds

Publications (2)

Publication Number Publication Date
FI950383A0 FI950383A0 (sv) 1995-01-27
FI950383A true FI950383A (sv) 1995-01-27

Family

ID=25448313

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950383A FI950383A (sv) 1992-07-31 1995-01-27 Nytt förfarande för framställning av kiralt (((2-brometyl)amino)-metyl)-2-nitro-1H-imidazol-1-etanol och därmed besläktade föreningar

Country Status (12)

Country Link
US (4) US5342959A (sv)
EP (1) EP0652870A1 (sv)
JP (1) JPH07509489A (sv)
KR (1) KR950702537A (sv)
AU (1) AU4784293A (sv)
CA (1) CA2136328A1 (sv)
CZ (1) CZ10395A3 (sv)
FI (1) FI950383A (sv)
HU (1) HUT71347A (sv)
MX (1) MX9304399A (sv)
SK (1) SK8495A3 (sv)
WO (1) WO1994015922A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5965621A (en) * 1995-08-17 1999-10-12 Allergan Methods and compositions for reducing or maintaining body weight in a mammal
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1590440A4 (en) * 2003-02-03 2009-03-18 Palo Alto Inst Of Molecular Me CELL-KILLING MOLECULES AND METHODS FOR THEIR USE
CN1314396C (zh) * 2005-04-28 2007-05-09 南京圣和药业有限公司 左旋奥硝唑在制备抗厌氧菌感染药物的应用
CN1332662C (zh) * 2005-04-29 2007-08-22 南京圣和药业有限公司 左旋奥硝唑的静脉给药制剂及其制备方法
CN1305469C (zh) * 2005-07-08 2007-03-21 南京圣和药业有限公司 左旋奥硝唑在制备抗寄生虫感染的药物中的应用
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
CN100368402C (zh) * 2005-11-16 2008-02-13 沈阳中海生物技术开发有限公司 奥硝唑光学对映体的制备方法
CN112774569B (zh) * 2021-01-11 2022-04-08 江门市华熊新材料有限公司 含氟咪唑表面活性剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
DE3367092D1 (en) * 1982-05-27 1986-11-27 Nat Res Dev Improvements relating to compounds useful in radiotherapy or chemotherapy
US4946496A (en) * 1982-06-01 1990-08-07 E. I. Du Pont De Nemours And Company Herbicidal diazoles
US5098921A (en) * 1987-12-04 1992-03-24 National Research Development Corporation Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.

Also Published As

Publication number Publication date
FI950383A0 (sv) 1995-01-27
US5481000A (en) 1996-01-02
KR950702537A (ko) 1995-07-29
US5543527A (en) 1996-08-06
US5659048A (en) 1997-08-19
WO1994015922A1 (en) 1994-07-21
JPH07509489A (ja) 1995-10-19
HUT71347A (en) 1995-11-28
SK8495A3 (en) 1995-08-09
AU4784293A (en) 1994-08-15
CZ10395A3 (en) 1995-11-15
HU9500269D0 (en) 1995-03-28
MX9304399A (es) 1994-02-28
CA2136328A1 (en) 1994-07-21
EP0652870A1 (en) 1995-05-17
US5342959A (en) 1994-08-30

Similar Documents

Publication Publication Date Title
FI950383A (sv) Nytt förfarande för framställning av kiralt (((2-brometyl)amino)-metyl)-2-nitro-1H-imidazol-1-etanol och därmed besläktade föreningar
FI945441A0 (sv) Nytt förfarande för framställning av 7beta-substituerad-4-aza-5alfa-androstan-3-oner
DE69526182D1 (de) Verfahren zur Herstellung von Trehalosederivaten
FI940769A (sv) Förfarande för framställning av 2-aminotiazolderivat
DE59207104D1 (de) Verfahren zur Herstellung von N-substituierten Lactamen
DE59308715D1 (de) Verfahren zur Herstellung von Dimethylchlorsilan
FI963050A0 (sv) Förfarande för framställning av ett klavulansyresalt
DE59305389D1 (de) Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen
DE69303547D1 (de) Verfahren zur Herstellung von unsymmetrischen Biarylderivaten
DE59402263D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolid-2-onen
DE69311213D1 (de) Verfahren zur Herstellung von 1-Aza-2-silacyclopentan-Verbindungen
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
DE69118001D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten
DE69207051D1 (de) Substituierte Acetoxyazetidinonderivate und Verfahren zur Herstellung von 4-Acyloxyazetidinonderivate
DE59309654D1 (de) Verfahren zur Herstellung von festem Natriumcyanid
DE69505332D1 (de) Verfahren zur Herstellung von Amidverbindungen
DE69424475D1 (de) Verfahren zur Herstellung von 1-(2'-deoxy-beta-D-erythropentofuranosyl)-5-trifluormethyluracil Derivaten
DE69216125D1 (de) Verfahren zur Herstellung von 2-Exo-methylenpenam-Derivaten
DE69221586D1 (de) Verfahren zur Herstellung von Oximinosilanverbindung
DE69602220D1 (de) Verfahren zur Verbesserung der thermischen Stabilität von Sepiolith
DE59407470D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE69319683D1 (de) Verfahren zur Herstellung von Thienothiopyran-Derivaten
DE59205760D1 (de) Verfahren zur Herstellung N-substituierter Nitro-p-phenylendiamine
DE69304839D1 (de) Verfahren zur Herstellung von Nukleosidderivaten
DE59208718D1 (de) Verfahren zur Herstellung von Imidazothiazolon-Derivaten

Legal Events

Date Code Title Description
FD Application lapsed